How does DNA methylation mark the fate of cells?

Tumori

Volumn 90, Issue 4, 2004, Pages 367-372

  Macaluso, Marcella ^a,b   Giordano, Antonio ^a,b  

^a Temple University   (United States)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Cancer; DNA methylation; Epigenetic alterations; Gene expression

Indexed keywords

CANCER GENETICS; CANCER GROWTH; CELL FATE; CHROMATIN STRUCTURE; CORRELATION ANALYSIS; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE REPRESSION; GENOME; GENOME IMPRINTING; HUMAN; MALIGNANT TRANSFORMATION; MAMMAL; MOLECULAR BIOLOGY; NONHUMAN; REGULATORY MECHANISM; REVIEW; TRANSPOSON; X CHROMOSOME INACTIVATION;

EID: 4644257411     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000401     Document Type: Review

References (72)

1. Bird A, Tate P, Nan X, Campoy J, Meehan R, Cross S, Tweedie S, Charlton J, Macleod D: Studies of DNA methylation in animals. J Cell Sci Suppl, 19: 37-39, 1995.
2. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev, 16: 6-21, 2002.
3. Antequera F and Bird A: Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90: 11995-11999, 1993.
4. Howlett SK, Reik W: Methylation levels of maternal and paternal genomes during preimplantation development. Development, 113: 119-127, 1991.
5. Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Gen (Suppl), 33: 245-254, 2003.
6. Zochbauer-Muller S, Minna JD, Gadzar AF: Aberrant DNA methylation in lung cancer: biological and clinical implication. Oncologist, 7: 451-457, 2003.
7. Jones PA: The DNA methylation paradox. TIG, 15: 34-37, 1999.
8. Szyf M: DNA methylation and cancer therapy. Drug Resist UpDat, 6: 341-353, 2003.
9. Meehan RR: DNA methylation in animal development. Semin Cell Dev Biol, 14: 53-65, 2003.
10. Lucifero D, Mann MR, Bartolomei MS, Trasler JM: Gene-specific timing and epigenetic memory in oocyte imprinting. Hum Mol Genet, 13: 839-849, 2004.
11. Dodge JE, Kang YK, Beppu H, Lei H, Li E: Histone H3-K9 Methytransferase ESET is essential for early development. Mol Cell Biol, 24: 2478-2486, 2004.
12. Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian development. Science, 293: 1089-1093, 2001.
13. Macaluso M, Paggi MG, Giordano A: Genetici and epigenetic alterations as hallmarks of the intricate road to cancer. Oncogene, 22: 6472-6478, 2003.
14. Razin A, Cedar H: DNA methylation and embryogenesis. EXS, 64: 343-357, 1993.
15. Kim Gd, NI J, Kelesoglu N, Roberts RJ, Pradhan S: Co-operation and communication between the human maintenance and the novo DNA (cytosine-5) methyltransferase. EMBO J, 21: 4183-4195, 2002.
16. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA: The human DNA methyltransferases (DNMTs),1, 3a, 3b: coordinate mRNA expression in normal tissue and overexpression in tumors. Nucleic Acids Res, 27: 2291-2298, 1999.
17. Xie S, Wang Z, Okano M, Nogami M, Li Y, He WW, Okumura K, Li E: Cloning, espression and chromosome location of the human DNMT3 gene family. Gene, 236: 87-95, 1999.
18. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet, (Suppl) 33: 245-254, 2003.
19. Okano M, Bell DW, Haber DA, Li E: DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell, 99: 247-257, 1999.
20. Bachman KE, Rountree MR, Baylin SB: Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem, 276: 32282-32287, 2001.
21. Bestor TH: The DNA methyltransferase of mammals. Hum Mol Genet, 9: 2395-2402, 2000.
22. Kim Gd, NI J, Kelesoglu N, Roberts RJ, Pradhan S: Co-operation and communication between the human maintenance and the novo DNA (cytosine-5) methyltransferase. EMBO J, 21, 4183-4195, 2002.
23. Howell CY Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, Chaillet JR: Genomic imprinting disrupted by a maternal effect mutation in DNMT1 gene. Cell, 104: 829-838, 2001.
24. Yoder JA, Bestor TH: A candidate mammalian DNA methyltansferase related to pmt1p of fission yeast. Hum Mol Genet, 7: 279-284, 1998.
25. Okano M, Xie S, Li E: DNMT2 is not required for the novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res, 26, 2536-2540, 1998.
26. Dong A, Yoder JA, Zhang X, Zhou L, Bestor TH, Cheng X: Structure of human DNMT2 an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acid Res, 29, 439-448, 2001.
27. Wilkinson CR, Bartlett R, Nurse P, Bird AP: The fission yeast gene pmt1 encodes a DNA methyltransferase homologue. Nucleic Acids Res, 23: 203-210, 1995.
28. Okuwaki M and Verreault A: Maintenance DNA methylation of nucleosome core particles. J Biol Chem, 279: 2904-2912, 2004.
29. Ge YZ, Pu MT, Gowher H, Wu HP, Ding JP, Jeltsch A, Xu GL: Chromatin targeting of the novo DNA methyltransferase by the PWWP domain. J Biol Chem. 279: 25447-25454, 2004.
30. Vermaak D, Ahmad K, Henikoff S: Maintenance of chromatin states: an open-and-shut case opinion. Curr Opin Cell Biol, 15: 266-274, 2003.
31. Heard E, Clerc P, Avner P: X-Chromosome inactivation in mammals. Annu Rev Genet, 31: 571-610, 1997.
32. Bartolomei MS and Tilghman SM: Genomic imprinting in mammals. Annu Rev Genet, 31: 493-525, 1997.
33. Falls JG, Pulford DJ, Wyllie AA, Jirtle RL: Genomic imprinting: implication for human disease. Am J Pathol, 154: 635-647, 1999.
34. Ng HH, Bird A: DNA methylation and chromatin modification. Curr Opin Genet Dev, 9: 158-163, 1999.
35. Newell-Price Clarck AJ, King P: DNA methylation and silencing of gene expression. TEM, 11: 142-148, 2000.
36. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393: 386-389, 1998.
37. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet, 19: 187-191, 1998.
38. Bird AP and Wolffe AP: Methylation-induced repression-belts, braces, and chromatin. Cell, 99: 451-454, 1999.
39. Meehan RR, Lewis JD, McKay S, Kleiner E, Bird AP: Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58: 499-507, 1989.
40. Lewis JD, Meehan RR, Henzel WJ, Welshons WV, Lubahn DB, Huang THM: Purification, sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69: 905-914, 1992.
41. Boy es J, Bird A: DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64: 1123-1134, 1991.
42. Jones PL, Sachs LM, Rouse N, Wade PA, Shi YB: Multiple N-CoR complexes contain distinct histone deacetylases. J Biol Chem, 276: 8807-8811, 2001.
43. Wade PA, Gegonne A, Jones PI, Ballestar E, Aubry F, Wolffe AP: Mi-2 complex couples DNA methylation to chromatin remodeling and histone deacetylation. Nat Genet, 23: 62-66, 1999.
44. Nan X, Meehan RR, Bird A: Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res, 21: 4886-4892, 1993.
45. Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481, 1997.
46. Hendrich B and Bird A: Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol, 18: 6538-6547, 1998.
47. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev, 13: 1924-1935, 1999.
48. Feng Q, Cao R, Xia L, Erdjument-Bromage H, Tempst P, Zhang Y: Identification and functional characterization of the p66,p68 component of the MeCP1 complex. Mol Cell Biol, 22: 536-546, 2002.
49. Strohner R, Nemeth A, Jansa P, Hofmann-Rohrer U, Santoro R, Langst G, Grummt I: NoRC a novel member of mammalian ISWI-containing chromatin remodeling machines. EMBO J, 20: 4892-4900, 2001.
50. Rountree MR, Bachman KE, Baylin SB: DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at a replication foci. Nat Genet, 25: 269-277, 2000.
51. Pradhan S and Kim GD: The retinoblastoma gene product interacts with the maintenance human DNA (cytosine-5) methyltransferase and modulates its activity. EMBO J, 21: 779-788, 2002.
52. Macaluso M, Cinti C, Russo G, Russo A, Giordano A: pRb2/p130-E2F4/5- HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-a in breast cancer. Oncogene, 22: 3511-3517, 2003.
53. Sherr CJ: Cancer cell cycles revisited. Cancer Res, 60: 3689-3695, 2000.
54. Sandal T: Molecular aspects of the mammalian cell cycle and cancer. Oncologist, 7: 73-81, 2002.
55. Strahl BD, Allis CD: The language of covalent histone modifications. Nature, 403: 41-45, 2000.
56. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393: 386-389, 1998.
57. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landesberger N, Strouboulis J, Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet, 19: 187-191, 1998.
58. Vignali M, Hassan AH, Neely KE, Workam JL: ATP-dependent chromatin remodeling complexes. Mol Cell Biol, 20: 1899-1910, 2000.
59. Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D, De Falco G, Russo G, Ammirati G, Maraldi MN, Giordano A, Cinti C: pRb2/p130 and p 107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J Cell Physiol, 83: 34-44, 2001.
60. La Sala D, Macaluso M, Trimarchi C, Giordano A, Cinti C: Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes. Oncogene, 22: 3518-3529, 2003.
61. Nephew KP, Huang TH: Epigenetic gene silencing in cancer initiation and progression. Cancer Lett, 190: 125-133, 2003.
62. Esteller M: Cancer epigenetics: DNA methylation and chromatin alteration in human cancer. Adv Exp Med Biol, 532: 39-49, 2003.
63. Jones PA, Baylin SB: The fundamental role of epigenetic event in cancer. Nat Rev Genet, 3: 415-428, 2002.
64. Gonzales-Quevedo R, Garcia-Aranda C, Moran A, De Juan C, Sanchez-Pernaute A, Torres A, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P: Differential impact of p16 inactivation by promoter methylation in non small cell lung and colorectal cancer: clinical implication. Int J Oncol, 24, 349-355, 2004.
65. Huag Q, Ai L, Zhang ZY, Fan CY, Weiss LM: Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China. Mod Pathol, 17: 416-422, 2004.
66. Esteller M, Herman JC: Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol, 196: 1-7, 2002.
67. Silva J, Silva JM, Dominguez G, Garcia JM, Cantos B, Rodriguez R, Larrondo FJ, Provencio M, Espana P, Bonilla F: Concomitant expression of p16 INK4a and p14 ARF in primary breast cancer and analysis of inactivation mechanisms. J Pathol, 199: 289-297, 2003.
68. Zheng S, Chen P, McMillan A, Lafuente MJ, Ballesta A, Trias M, Wiencke JK: Correlations of partial and extensive methylation at the p14 (ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis, 21: 2057-2064, 2000.
69. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancer. Cancer Res, 61: 249-255, 2001.
70. Toyota M, Itoh F, Kikuchi T, Satoh A, Obata T, Suzuki H, Ishii S, Endo T, Tokino T and Imai K: DNA methylation changes in gastrointestinal disease. J Gastroenterol, 37: 97-101, 2002.
71. Bestor TH: Unaswered questions about the role of promoter methylation in carcinogenesis. Ann NY Acad Sci, 987: 22-27, 2003.
72. Zochbauer-Muller S, Minna JD, Gazdar AF: Aberrant DNA methylation in lung cancer. Oncologist, 7: 451-456, 2002.